In our study only 1 patient discontinued TERI due to ALT increase and the others stopped treatment because of pancreatitis, generalized pain and one patient stopped treatment because of multiple AEs including menstrual irregularity, alopecia, migraine attacks. The gene discussed is GPT; the disease is migraine disorder.